Robert Duggan (CEO)

Robert Duggan, 70, is a private venture investor and was CEO of surgical systems maker Computer Motion.[1] He is the CEO of Pharmacyclics, a biotech drugmaker traded on NASDAQ. Duggan will receive over $3.5 billion from the sale of his company to AbbVie in "one of the biggest paydays ever from the buyout of a publicly held company".[2][1][3][4] [5] He is a philanthropist who graduated from University of California, Santa Barbara.[6]

References

  1. ↑ 1.0 1.1 "The $3.55 billion Man". America's Markets.
  2. ↑ Antoine Gara. "Robert Duggan". Forbes.
  3. ↑ "Pharmacyclics May Soon Be Acquired by Johnson & Johnson for $18 Billion". Science Times.
  4. ↑ "The Hiring Guru: Robert Duggan Billionaire". The Huffington Post.
  5. ↑ Sean Williams (27 February 2013). "This Is One Incredible CEO". fool.com.
  6. ↑ "Robert Duggan Gives Back to University". PRWeb. 21 April 2014.

External links